AI assistant
Sending…
Larimar Therapeutics, Inc. — Director's Dealing 2016
Jul 26, 2016
33359_dirs_2016-07-26_87d6e84d-0667-42d8-9190-e8ccca3d95e1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ZAFGEN, INC. (ZFGN)
CIK: 0001374690
Period of Report: 2016-07-22
Reporting Person: Heller Frances K (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-07-22 | Common Stock | P | 10000 | $2.99 | Acquired | 10000 | Direct |
More from Larimar Therapeutics, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Mar 19
Annual Report
2026
Mar 19
Earnings Release
2026
Mar 19
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2